0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Plerixafor Market Insights, Forecast to 2030
Published Date: December 2024
|
Report Code: QYRE-Auto-10B6035
Home | Market Reports | Health| Pharmacy
Global and United States Plerixafor Market Report Forecast 2022 2028
BUY CHAPTERS

Global Plerixafor Market Insights, Forecast to 2030

Code: QYRE-Auto-10B6035
Report
December 2024
Pages:75
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Plerixafor Market

Plerixafor (INN and USAN, trade name Mozobil) is an immunostimulant used to mobilize hematopoietic stem cells in cancer patients into the bloodstream.
Market Analysis and Insights: Global Plerixafor Market
The global Plerixafor market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The US & Canada market for Plerixafor is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The China market for Plerixafor is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The Europe market for Plerixafor is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The global key companies of Plerixafor include sanofi-aventis. etc. In 2023, the global top five players had a share approximately % in terms of revenue.
Plerixafor is widely used in various fields, such as Non-Hodgkin's lymphoma (NHL) Patients and Multiple myeloma (MM) Patients, etc. Non-Hodgkin's lymphoma (NHL) Patients provides greatest supports to the Plerixafor industry development. In 2023, global % revenue of Plerixafor went into Non-Hodgkin's lymphoma (NHL) Patients filed and the proportion will reach to % in 2030.
Report Covers:
This report presents an overview of global market for Plerixafor market size. Analyses of the global market trends, with historic market revenue data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Plerixafor, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Plerixafor, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Plerixafor revenue, market share and industry ranking of main companies, data from 2019 to 2024. Identification of the major stakeholders in the global Plerixafor market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2019 to 2030. Evaluation and forecast the market size for Plerixafor revenue, projected growth trends, production technology, application and end-user industry.
Market Segmentation

Scope of Plerixafor Market Report

Report Metric Details
Report Name Plerixafor Market
Segment by Type
  • 24MG/1.2ML
  • Type II
Segment by Application
  • Non-Hodgkin's lymphoma (NHL) Patients
  • Multiple myeloma (MM) Patients
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company sanofi-aventis
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Revenue of Plerixafor in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Plerixafor companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: North America (US & Canada) by Type, by Application and by country, revenue for each segment.
  • Chapter 7: Europe by Type, by Application and by country, revenue for each segment.
  • Chapter 8: China by Type, and by Application, revenue for each segment.
  • Chapter 9: Asia (excluding China) by Type, by Application and by region, revenue for each segment.
  • Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, revenue for each segment.
  • Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Plerixafor revenue, gross margin, and recent development, etc.
  • Chapter 12: Analyst's Viewpoints/Conclusions

FAQ for this report

Who are the main players in the Plerixafor Market report?

Ans: The main players in the Plerixafor Market are sanofi-aventis

What are the Application segmentation covered in the Plerixafor Market report?

Ans: The Applications covered in the Plerixafor Market report are Non-Hodgkin's lymphoma (NHL) Patients, Multiple myeloma (MM) Patients

What are the Type segmentation covered in the Plerixafor Market report?

Ans: The Types covered in the Plerixafor Market report are 24MG/1.2ML, Type II

Recommended Reports

Cancer Therapeutics

Lymphoma & Leukemia

Anticancer & APIs

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Plerixafor Market Size Growth Rate by Type, 2019 VS 2023 VS 2030
1.2.2 24MG/1.2ML
1.2.3
1.3 Market by Application
1.3.1 Global Plerixafor Market Size Growth Rate by Application, 2019 VS 2023 VS 2030
1.3.2 Non-Hodgkin's lymphoma (NHL) Patients
1.3.3 Multiple myeloma (MM) Patients
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Plerixafor Market Perspective (2019-2030)
2.2 Global Plerixafor Growth Trends by Region
2.2.1 Plerixafor Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Plerixafor Historic Market Size by Region (2019-2024)
2.2.3 Plerixafor Forecasted Market Size by Region (2025-2030)
2.3 Plerixafor Market Dynamics
2.3.1 Plerixafor Industry Trends
2.3.2 Plerixafor Market Drivers
2.3.3 Plerixafor Market Challenges
2.3.4 Plerixafor Market Restraints
3 Competition Landscape by Key Players
3.1 Global Revenue Plerixafor by Players
3.1.1 Global Plerixafor Revenue by Players (2019-2024)
3.1.2 Global Plerixafor Revenue Market Share by Players (2019-2024)
3.2 Global Plerixafor Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of Plerixafor, Ranking by Revenue, 2022 VS 2023 VS 2024
3.4 Global Plerixafor Market Concentration Ratio
3.4.1 Global Plerixafor Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Plerixafor Revenue in 2023
3.5 Global Key Players of Plerixafor Head office and Area Served
3.6 Global Key Players of Plerixafor, Product and Application
3.7 Global Key Players of Plerixafor, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Plerixafor Breakdown Data by Type
4.1 Global Plerixafor Historic Market Size by Type (2019-2024)
4.2 Global Plerixafor Forecasted Market Size by Type (2025-2030)
5 Plerixafor Breakdown Data by Application
5.1 Global Plerixafor Historic Market Size by Application (2019-2024)
5.2 Global Plerixafor Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Plerixafor Market Size (2019-2030)
6.2 North America Plerixafor Market Size by Type
6.2.1 North America Plerixafor Market Size by Type (2019-2024)
6.2.2 North America Plerixafor Market Size by Type (2025-2030)
6.2.3 North America Plerixafor Market Share by Type (2019-2030)
6.3 North America Plerixafor Market Size by Application
6.3.1 North America Plerixafor Market Size by Application (2019-2024)
6.3.2 North America Plerixafor Market Size by Application (2025-2030)
6.3.3 North America Plerixafor Market Share by Application (2019-2030)
6.4 North America Plerixafor Market Size by Country
6.4.1 North America Plerixafor Market Size by Country: 2019 VS 2023 VS 2030
6.4.2 North America Plerixafor Market Size by Country (2019-2024)
6.4.3 North America Plerixafor Market Size by Country (2025-2030)
6.4.4 U.S.
6.4.5 Canada
7 Europe
7.1 Europe Plerixafor Market Size (2019-2030)
7.2 Europe Plerixafor Market Size by Type
7.2.1 Europe Plerixafor Market Size by Type (2019-2024)
7.2.2 Europe Plerixafor Market Size by Type (2025-2030)
7.2.3 Europe Plerixafor Market Share by Type (2019-2030)
7.3 Europe Plerixafor Market Size by Application
7.3.1 Europe Plerixafor Market Size by Application (2019-2024)
7.3.2 Europe Plerixafor Market Size by Application (2025-2030)
7.3.3 Europe Plerixafor Market Share by Application (2019-2030)
7.4 Europe Plerixafor Market Size by Country
7.4.1 Europe Plerixafor Market Size by Country: 2019 VS 2023 VS 2030
7.4.2 Europe Plerixafor Market Size by Country (2019-2024)
7.4.3 Europe Plerixafor Market Size by Country (2025-2030)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 China
8.1 China Plerixafor Market Size (2019-2030)
8.2 China Plerixafor Market Size by Type
8.2.1 China Plerixafor Market Size by Type (2019-2024)
8.2.2 China Plerixafor Market Size by Type (2025-2030)
8.2.3 China Plerixafor Market Share by Type (2019-2030)
8.3 China Plerixafor Market Size by Application
8.3.1 China Plerixafor Market Size by Application (2019-2024)
8.3.2 China Plerixafor Market Size by Application (2025-2030)
8.3.3 China Plerixafor Market Share by Application (2019-2030)
9 Asia (excluding China)
9.1 Asia Plerixafor Market Size (2019-2030)
9.2 Asia Plerixafor Market Size by Type
9.2.1 Asia Plerixafor Market Size by Type (2019-2024)
9.2.2 Asia Plerixafor Market Size by Type (2025-2030)
9.2.3 Asia Plerixafor Market Share by Type (2019-2030)
9.3 Asia Plerixafor Market Size by Application
9.3.1 Asia Plerixafor Market Size by Application (2019-2024)
9.3.2 Asia Plerixafor Market Size by Application (2025-2030)
9.3.3 Asia Plerixafor Market Share by Application (2019-2030)
9.4 Asia Plerixafor Market Size by Region
9.4.1 Asia Plerixafor Market Size by Region: 2019 VS 2023 VS 2030
9.4.2 Asia Plerixafor Market Size by Region (2019-2024)
9.4.3 Asia Plerixafor Market Size by Region (2025-2030)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 Middle East, Africa, and Latin America
10.1 Middle East, Africa, and Latin America Plerixafor Market Size (2019-2030)
10.2 Middle East, Africa, and Latin America Plerixafor Market Size by Type
10.2.1 Middle East, Africa, and Latin America Plerixafor Market Size by Type (2019-2024)
10.2.2 Middle East, Africa, and Latin America Plerixafor Market Size by Type (2025-2030)
10.2.3 Middle East, Africa, and Latin America Plerixafor Market Share by Type (2019-2030)
10.3 Middle East, Africa, and Latin America Plerixafor Market Size by Application
10.3.1 Middle East, Africa, and Latin America Plerixafor Market Size by Application (2019-2024)
10.3.2 Middle East, Africa, and Latin America Plerixafor Market Size by Application (2025-2030)
10.3.3 Middle East, Africa, and Latin America Plerixafor Market Share by Application (2019-2030)
10.4 Middle East, Africa, and Latin America Plerixafor Market Size by Country
10.4.1 Middle East, Africa, and Latin America Plerixafor Market Size by Country: 2019 VS 2023 VS 2030
10.4.2 Middle East, Africa, and Latin America Plerixafor Market Size by Country (2019-2024)
10.4.3 Middle East, Africa, and Latin America Plerixafor Market Size by Country (2025-2030)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 Key Players Profiles
11.1 sanofi-aventis
11.1.1 sanofi-aventis Company Details
11.1.2 sanofi-aventis Business Overview
11.1.3 sanofi-aventis Plerixafor Introduction
11.1.4 sanofi-aventis Revenue in Plerixafor Business (2019-2024)
11.1.5 sanofi-aventis Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
    Table 1. Global Plerixafor Market Size Growth Rate by Type (US$ Million), 2019 VS 2023 VS 2030
    Table 2. Key Players of 24MG/1.2ML
    Table 3. Key Players of Type II
    Table 4. Global Plerixafor Market Size Growth Rate by Application (US$ Million), 2019 VS 2023 VS 2030
    Table 5. Global Plerixafor Market Size Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030
    Table 6. Global Plerixafor Market Size by Region (2019-2024) & (US$ Million)
    Table 7. Global Plerixafor Market Share by Region (2019-2024)
    Table 8. Global Plerixafor Forecasted Market Size by Region (2025-2030) & (US$ Million)
    Table 9. Global Plerixafor Market Share by Region (2025-2030)
    Table 10. Plerixafor Market Trends
    Table 11. Plerixafor Market Drivers
    Table 12. Plerixafor Market Challenges
    Table 13. Plerixafor Market Restraints
    Table 14. Global Plerixafor Revenue by Players (2019-2024) & (US$ Million)
    Table 15. Global Plerixafor Revenue Share by Players (2019-2024)
    Table 16. Global Top Plerixafor by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Plerixafor as of 2023)
    Table 17. Global Plerixafor Industry Ranking 2022 VS 2023 VS 2024
    Table 18. Global 5 Largest Players Market Share by Plerixafor Revenue (CR5 and HHI) & (2019-2024)
    Table 19. Global Key Players of Plerixafor, Headquarters and Area Served
    Table 20. Global Key Players of Plerixafor, Product and Application
    Table 21. Global Key Players of Plerixafor, Product and Application
    Table 22. Mergers & Acquisitions, Expansion Plans
    Table 23. Global Plerixafor Market Size by Type (2019-2024) & (US$ Million)
    Table 24. Global Plerixafor Revenue Market Share by Type (2019-2024)
    Table 25. Global Plerixafor Forecasted Market Size by Type (2025-2030) & (US$ Million)
    Table 26. Global Plerixafor Revenue Market Share by Type (2025-2030)
    Table 27. Global Plerixafor Market Size by Application (2019-2024) & (US$ Million)
    Table 28. Global Plerixafor Revenue Share by Application (2019-2024)
    Table 29. Global Plerixafor Forecasted Market Size by Application (2025-2030) & (US$ Million)
    Table 30. Global Plerixafor Revenue Share by Application (2025-2030)
    Table 31. North America Plerixafor Market Size by Type (2019-2024) & (US$ Million)
    Table 32. North America Plerixafor Market Size by Type (2025-2030) & (US$ Million)
    Table 33. North America Plerixafor Market Size by Application (2019-2024) & (US$ Million)
    Table 34. North America Plerixafor Market Size by Application (2025-2030) & (US$ Million)
    Table 35. North America Plerixafor Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 36. North America Plerixafor Market Size by Country (2019-2024) & (US$ Million)
    Table 37. North America Plerixafor Market Size by Country (2025-2030) & (US$ Million)
    Table 38. Europe Plerixafor Market Size by Type (2019-2024) & (US$ Million)
    Table 39. Europe Plerixafor Market Size by Type (2025-2030) & (US$ Million)
    Table 40. Europe Plerixafor Market Size by Application (2019-2024) & (US$ Million)
    Table 41. Europe Plerixafor Market Size by Application (2025-2030) & (US$ Million)
    Table 42. Europe Plerixafor Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 43. Europe Plerixafor Market Size by Country (2019-2024) & (US$ Million)
    Table 44. Europe Plerixafor Market Size by Country (2025-2030) & (US$ Million)
    Table 45. China Plerixafor Market Size by Type (2019-2024) & (US$ Million)
    Table 46. China Plerixafor Market Size by Type (2025-2030) & (US$ Million)
    Table 47. China Plerixafor Market Size by Application (2019-2024) & (US$ Million)
    Table 48. China Plerixafor Market Size by Application (2025-2030) & (US$ Million)
    Table 49. Asia Plerixafor Market Size by Type (2019-2024) & (US$ Million)
    Table 50. Asia Plerixafor Market Size by Type (2025-2030) & (US$ Million)
    Table 51. Asia Plerixafor Market Size by Application (2019-2024) & (US$ Million)
    Table 52. Asia Plerixafor Market Size by Application (2025-2030) & (US$ Million)
    Table 53. Asia Plerixafor Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030
    Table 54. Asia Plerixafor Market Size by Region (2019-2024) & (US$ Million)
    Table 55. Asia Plerixafor Market Size by Region (2025-2030) & (US$ Million)
    Table 56. Middle East, Africa, and Latin America Plerixafor Market Size by Type (2019-2024) & (US$ Million)
    Table 57. Middle East, Africa, and Latin America Plerixafor Market Size by Type (2025-2030) & (US$ Million)
    Table 58. Middle East, Africa, and Latin America Plerixafor Market Size by Application (2019-2024) & (US$ Million)
    Table 59. Middle East, Africa, and Latin America Plerixafor Market Size by Application (2025-2030) & (US$ Million)
    Table 60. Middle East, Africa, and Latin America Plerixafor Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 61. Middle East, Africa, and Latin America Plerixafor Market Size by Country (2019-2024) & (US$ Million)
    Table 62. Middle East, Africa, and Latin America Plerixafor Market Size by Country (2025-2030) & (US$ Million)
    Table 63. sanofi-aventis Company Details
    Table 64. sanofi-aventis Business Overview
    Table 65. sanofi-aventis Plerixafor Product
    Table 66. sanofi-aventis Revenue in Plerixafor Business (2019-2024) & (US$ Million)
    Table 67. sanofi-aventis Recent Developments
    Table 68. Research Programs/Design for This Report
    Table 69. Key Data Information from Secondary Sources
    Table 70. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Plerixafor Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 2. Global Plerixafor Market Share by Type: 2023 VS 2030
    Figure 3. 24MG/1.2ML Features
    Figure 4. Type II Features
    Figure 5. Global Plerixafor Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 6. Global Plerixafor Market Share by Application: 2023 VS 2030
    Figure 7. Non-Hodgkin's lymphoma (NHL) Patients Case Studies
    Figure 8. Multiple myeloma (MM) Patients Case Studies
    Figure 9. Plerixafor Report Years Considered
    Figure 10. Global Plerixafor Market Size (US$ Million), Year-over-Year: 2019-2030
    Figure 11. Global Plerixafor Market Size, (US$ Million), 2019 VS 2023 VS 2030
    Figure 12. Global Plerixafor Market Share by Region: 2023 VS 2030
    Figure 13. Global Plerixafor Market Share by Players in 2023
    Figure 14. Global Top Plerixafor Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Plerixafor as of 2023)
    Figure 15. The Top 10 and 5 Players Market Share by Plerixafor Revenue in 2023
    Figure 16. North America Plerixafor Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 17. North America Plerixafor Market Share by Type (2019-2030)
    Figure 18. North America Plerixafor Market Share by Application (2019-2030)
    Figure 19. North America Plerixafor Market Share by Country (2019-2030)
    Figure 20. United States Plerixafor Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 21. Canada Plerixafor Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 22. Europe Plerixafor Market Size YoY (2019-2030) & (US$ Million)
    Figure 23. Europe Plerixafor Market Share by Type (2019-2030)
    Figure 24. Europe Plerixafor Market Share by Application (2019-2030)
    Figure 25. Europe Plerixafor Market Share by Country (2019-2030)
    Figure 26. Germany Plerixafor Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 27. France Plerixafor Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 28. U.K. Plerixafor Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 29. Italy Plerixafor Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 30. Russia Plerixafor Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 31. Nordic Countries Plerixafor Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 32. China Plerixafor Market Size YoY (2019-2030) & (US$ Million)
    Figure 33. China Plerixafor Market Share by Type (2019-2030)
    Figure 34. China Plerixafor Market Share by Application (2019-2030)
    Figure 35. Asia Plerixafor Market Size YoY (2019-2030) & (US$ Million)
    Figure 36. Asia Plerixafor Market Share by Type (2019-2030)
    Figure 37. Asia Plerixafor Market Share by Application (2019-2030)
    Figure 38. Asia Plerixafor Market Share by Region (2019-2030)
    Figure 39. Japan Plerixafor Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 40. South Korea Plerixafor Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 41. China Taiwan Plerixafor Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 42. Southeast Asia Plerixafor Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 43. India Plerixafor Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 44. Australia Plerixafor Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 45. Middle East, Africa, and Latin America Plerixafor Market Size YoY (2019-2030) & (US$ Million)
    Figure 46. Middle East, Africa, and Latin America Plerixafor Market Share by Type (2019-2030)
    Figure 47. Middle East, Africa, and Latin America Plerixafor Market Share by Application (2019-2030)
    Figure 48. Middle East, Africa, and Latin America Plerixafor Market Share by Country (2019-2030)
    Figure 49. Brazil Plerixafor Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 50. Mexico Plerixafor Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 51. Turkey Plerixafor Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 52. Saudi Arabia Plerixafor Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 53. Israel Plerixafor Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 54. GCC Countries Plerixafor Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 55. sanofi-aventis Revenue Growth Rate in Plerixafor Business (2019-2024)
    Figure 56. Bottom-up and Top-down Approaches for This Report
    Figure 57. Data Triangulation
    Figure 58. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$4900

This license allows only one user to access the PDF.
Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Nano Dimension

SIMILAR REPORTS

RELATED REPORTS

Global GLP-1 Targeted Peptide Weight Loss Drugs Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-19A18322
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Stimulant-Free Fat Burners Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-3E3525
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Test Boosters Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-35T3049
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Salsalate Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-33Y1801
Thu Sep 11 00:00:00 UTC 2025

Add to Cart